mTOR inhibitor 9c

CAS No. 1144075-36-4

mTOR inhibitor 9c( —— )

Catalog No. M35934 CAS No. 1144075-36-4

mTOR inhibitor 9c is a selective mTOR inhibitor with IC50 of 0.7nM and 825nM for mTOR and PI3Kα, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 299 Get Quote
5MG 455 Get Quote
10MG 620 Get Quote
25MG 911 Get Quote
50MG 1224 Get Quote
100MG 1575 Get Quote
200MG 2133 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    mTOR inhibitor 9c
  • Note
    Research use only, not for human use.
  • Brief Description
    mTOR inhibitor 9c is a selective mTOR inhibitor with IC50 of 0.7nM and 825nM for mTOR and PI3Kα, respectively.
  • Description
    mTOR inhibitor 9c is a selective mTOR inhibitor with IC50 of 0.7nM and 825nM for mTOR and PI3Kα, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    mTOR | PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1144075-36-4
  • Formula Weight
    427.5
  • Molecular Formula
    C21H22FN5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(NCCF)=O)C1=CC=C(C2=NC(=C3C(=N2)C=CS3)N4CC5OC(C4)CC5)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SR9011

    SR9011 is a REV-ERB agonist (IC50: 790 nM, REV-ERBα; IC50: 560 nM, REV-ERBβ).

  • DMH-25

    DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.

  • ML239

    ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.